Alpharmagen LLC
Records under this name other than patents Alpharmagen LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Alpharmagen LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,434,724 | Quinuclidines for modulating alpha 7 activity Lapsed on the fee record Ended Sep 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2024 | From the USPTO record |
| US 8,114,891 | 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof Lapsed on the fee record Ended Feb 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 14, 2024 | From the USPTO record |
| US 8,563,579 | α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof Lapsed on the fee record Ended Oct 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2021 | From the USPTO record |
| US 8,975,407 | α7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof Lapsed on the fee record Ended Mar 10, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2019 | From the USPTO record |